General anaesthesia may predispose patients to aspiration of gastroesophageal contents because of depression of protective reflexes. Although the incidence of aspiration has remained infrequent and relatively constant, there has been a marked increase in the extent of surgery undertaken in the sick, more elderly population 1 . Since Mendelson's description of aspiration pneumonia in 1946, many methods and drugs have been used to prevent aspiration or to reduce the damage due to aspiration 2 . The degree of damage is associated with the pH and volume of the substance aspirated. A pH 2.5 and volume 25 ml (0.4 ml.kg) of aspirated substance have been suggested as critical values (Roberts-Shirley criteria) for the development of acid aspiration syndrome [3] [4] [5] . Precautions such as preoperative fasting or increasing gastric emptying prior to the operation have not been reliable. H 2 receptor antagonists inhibit secretion of gastric acid, decreasing both pH and volume of gastric contents 3 . Cimetidine, ranitidine, famotidine, and recently, nizatidine have been used for this purpose.
Erythromycin is a macrolide antibiotic with a side-effect of strong gastric contractions at therapeutic dosages of 500-1000 mg. At a low dosage of 200 mg, it causes intermittent gastric contractions which spread to the small intestine [6] [7] [8] . It has been demonstrated in healthy volunteers that erythromycin at low doses increases gastric emptying 9 . In our study of patients scheduled for elective surgery, we aimed to compare the effects of oral erythromycin, nizatidine or placebo given one hour prior to operation on gastric acidity and volume.
MATERIALS AND METHOD
After obtaining approval from the Ethics Committee and informed written consent, the study was conducted on 60 ASA 1-2 patients who were scheduled for elective surgery. Patients with gastrointestinal diseases and those on medication which might have altered gastric motility were excluded from the study. The study design was randomized and double-blinded with patients allocated according to a computer-generated randomization. The patients were randomized to three groups of 20 patients each. Sixty minutes before the operation, erythromycin 200 mg with 10 ml water was given orally to Group 1 (n=20), oral nizatidine 300 mg with 10 ml water was given to Group 2 (n=20), and placebo capsule with 10 ml water (placebo=isotonic sodium chloride solution) were given to Group 3 (n=20). Evaluation of gastric content was done by an anaesthesia assistant blinded to the drug administered. The study drugs were prepared by the pharmacy, and an appropriate code number was assigned.
All of the patients were fasted preoperatively for six hours for solid food, four hours for liquid, and no other premedication was given 10 . In the operating room, intravenous crytalloid infusion and monitoring were initiated. Patients were intubated after anaesthesia induction with 2 mg/kg propofol IV, and 0.5 mg/kg atracurium IV. Anaesthesia was maintainaned with 50% oxygen in nitrous oxide and 1 to 1.5% isoflurane. Muscle relaxation was maintained with 0.2 mg/kg atracurium IV according to relaxometry. Following tracheal intubation, an anaesthesia specialist who did not know which drug was given to the patient, placed a nasogastric tube (Levine type). The correct location of the tube was verified by auscultation of the epigastrium while air was injected into the tube. Gastric content was aspirated and the volume recorded. The pH of the gastric content extracted was measured using a WTW-pH meter INOLAB (sensitive to 0.001) and recorded. Patients with gastric content pH 2.5 and volume 25 ml were classified as "at risk" of injury in case of aspiration. After aspiration of gastric contents 1 µg/kg fentanyl IV was given to all patients. The patients were extubated after the operation, kept under observation in PACU, then transferred to the ward. In the ward, the patients were kept under surveillance of an anaesthesia specialist who did not know which drug had been given to the patient, for 24 hours, for side-effects such as nausea and vomiting.
Student's t test was used to analyse the demographic data related to the patients, the post-hoc method of Bonferroni to analyse the gastric content pH and volume, and the chi-square test to establish the acid aspiration syndrome risk. P<0.05 was accepted as statistically significant and P<0.001 as highly statistically significant.
RESULTS
The demographic data of the patients are presented in Table 1 . There were no statistically significant differences between the groups (P>0.05).
Gastric content pH value was 5.6±1.87 in Group 1, 5.65±1.92 in Group 2, and 3.5±1.93 in Group 3. There was no statistically significant difference between Groups 1 and 2, but the difference between Groups 1 and 2 when compared with Group 3 was highly statistically significant (P<0.001). The gastric content volume was 10.25±16.72 ml (mean±SD) in Group 1, 10.3±6.29 ml in Group 2, and 20.25± 16.72 ml in Group 3. There was no statistically significant difference between Groups 1 and 2, but the volume of the gastric contents was significantly lower (P<0.05) in Groups 1 and 2 in comparison to Group 3 ( Table 2) .
The proportion of patients classified as "higher risk" in case of aspiration was 10% in Group 1, 5% in Group 2, and 20% in Group 3 ( There were no statistically significant differences between the groups. acid aspiration risk in group 3 was somewhat higher than in Groups 1 and 2, the difference was not statistically significant. There were no side-effects observed in any of the groups.
DISCUSSION
The level of damage to the lungs as a result of the aspiration of gastric content depends on the pH and the volume of the aspirated substance. A pH 2.5 and volume 25 ml (0.4 ml.kg) of aspirated gastric contents have been suggested as critical values (Roberts-Shirley criteria) for the development of acid aspiration syndrome 3,4,5 . Raidoo et al 11 have suggested that a volume of 0.8 ml.kg is acceptable, however, the reduction in the pH is more important for development of aspiration pneumonia. Examination of the literature suggests that the incidence of pulmonary aspiration in the perioperative period is relatively infrequent and that there has been little change in the last few years 1 . In 1986, a study of Scandinavian Teaching Hospitals suggested that the incidence of aspiration varied between 0.7 and 4.7 per 10,000 general anaesthetics 12 . A report published one decade later suggested that the incidence was 2.9 per 10,000 at a Norwegian hospital 13 . In our study, oral erythromycin or nizatidine were administered at low dosage prior to the operation to patients who were undergoing elective surgery. We aimed to compare the effects of these drugs on gastric acidity and volume with a control group.
Erythromycin is a macrolide antibiotic 14 . Narchi et al 15 have administered erythromycin 500 mg IV in combination with 200 ml 5% dextrose, 30 minutes before the induction of anaesthesia to patients having laparoscopic surgery. They concluded that erythromycin reduces residual gastric volume and acidity. Asai et al 16 have given oral low dose (200 mg) erythromycin at three hours and one hour prior to the induction of anaesthesia and compared the effect of erythromycin on gastric content volume and acidity. They demonstrated that administering oral erythromycin three hours before induction of anaesthesia results in a reduction in the residual gastric volume but does not affect the acidity, whereas administering it one hour before induction of anaesthesia reduces both residual volume and the acidity. Our study confirms this finding, with the acidity and volume lower in the group administered erythromycin one hour before the induction of anaesthesia, compared with the placebo group.
Erythromycin has a side-effect of strong gastric contractions at therapeutic dosages of 500 to 1000 mg. At a low dosage of 200 mg, it causes intermittent gastric contractions which spread to the small intestine [6] [7] [8] . The effect of reducing the gastric content volume by erythromycin administered before the induction of anaesthesia can be explained by this mechanism. Although the mechanism by which erythromycin reduces gastric acidity is not fully known, it might be doing so by directly affecting motilin receptors. Motilin is a 22-amino acid gastrointestinal peptide which produces an active motor complex 7, 16, 17 . It has been shown that injection of erythromycin increases the secretion of motilin in dogs, and that motilin inhibits secretion of gastric acid in animals 18, 19 . Both erythromycin and motilin increase the secretion of pepsinogens in pigs, confirming the hypothesis that erythromycin directly affects the stomach 20 . These views support our findings of the reduction in gastric acidity. H 2 receptor antagonists inhibit secretion of gastric acid, leading to a reduction in both the pH and volume of gastric contents 3 . Nizatidine is a potent H 2 receptor antagonist which reduces both the volume and the H + ion concentration of the gastric acid secreted. It has been shown that the anti-secretory effect of nizatidine commences one to two hours after pH of gastric content; there were no statistically differences between Groups 1 and 2, while the difference between Groups 1 and 2 and Group 3 was statistically highly significant (P<0.001). Gastric content volume; there were no statistically significant differences between Groups 1 and 2, and the gastric content volume was significantly lower (P<0.05)in Groups 1 and 2 compared to Group 3. Patients with gastric content volume 25 ml 2 10 2 10 5 25
Patients with gastric content pH 2.5 and volume 25 ml 2 10 1 5 4 20
There were no statistically significant differences between the groups.
an oral dose of nizatidine 150 to 300 mg 21 . Nizatidine inhibits gastric acid secretion stimulated by pentagastrin, caffeine and betazol, without altering the serum concentration of gastrin. It has the advantage of not interacting with the hepatic cytochrome P-450 enzyme system, thus preventing drug interactions mediated by hepatic metabolism 22, 23 .
Mikawa et al 24 showed that a single oral dose of nizatidine 6 mg/kg administered on the morning of surgery increased the pH of the gastric content significantly (5.7 ±0.3) compared to placebo (1.8 ±0.2), and decreased the volume of the gastric content (P<0.05). The study has also showed a significant decrease in the proportion of at-risk patients, 4% in the nizatidine group versus 46% in the placebo group. Another study of oral nizatidine 150 mg given 45 minutes before gynaecological laparoscopic procedures 25 showed a significant increase in the pH of the gastric content but no significant difference in volume compared to the placebo group. While no patient in the nizatidine group was classified as at risk from acid aspiration syndrome, two patients (7.1%) in the placebo group were designated as at-risk.
In our study, we have established that 300 mg oral nizatidine given before induction of anaesthesia to patients scheduled for elective surgery significantly increased the pH of gastric content and decreased its volume. While the pH values of other researchers 24, 25 were similiar to our findings, the gastric content volume related findings of Popat et al 25 were different. This may be because they used half the dose we used.
Our literature search did not reveal any studies assessing erythromycin and acid aspiration risk. Previous studies of nizatidine have shown an at-risk incidence of 0% 25 and 4% 24 similiar to our 5%. Our results in the placebo group (20%) were higher than those (7.1%) of Popat et al 25 but lower than those (22%) of Mikawa et al 24 .
We have used erythromycin and nizatidine one hour before operation. Timing is important in daystay and acute patients. We found both drugs to be effective when given one hour prior to induction.
Erythromycin administered at therapeutic doses may cause complications such as gastric irritation, nausea and vomiting 26, 8 . There were no complications in our erythromycin group. Nizatidine may be associated with headache somnolence, rhinitis, pharyngitis, itching and diarrhoea 22, 23, 27 . In a placebocontrolled study, the rate of discontinuing treatment due to unwanted side-effects was found to be 2.5% with nizatidine and 6.5% with placebo 22 . In our study no side-effects were observed in the nizatidine group.
We conclude that oral erythromycin and nizatidine administered one hour before surgery may be useful in decreasing the volume and increasing the pH of gastric content and thus reduce the proportion of patients at risk of significant lung injury should aspiration occur.
